These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4391736)

  • 1. Comparative actions of beta-adrenergic receptor blocking drugs on the contractile and electrical properties of isolated human atrial muscle.
    Levy JV
    Cardiologia (Basel); 1968; 53(5):293-305. PubMed ID: 4391736
    [No Abstract]   [Full Text] [Related]  

  • 2. The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle.
    Nayler WG; Chipperfield D; Lowe TE
    Cardiovasc Res; 1969 Jan; 3(1):30-6. PubMed ID: 4391090
    [No Abstract]   [Full Text] [Related]  

  • 3. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
    Singh BN; Williams EM
    Br J Pharmacol; 1971 Sep; 43(1):10-22. PubMed ID: 4400181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of practolol and propranolol on the rabbit isolated atrium.
    Wale J
    Eur J Pharmacol; 1970 Mar; 9(3):387-90. PubMed ID: 4392487
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
    Hashimoto K; Endoh M; Tamura K; Taira N
    Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of the adrenergic drugs on the electrical responses of the rabbit isolated heart atrium.
    Smejkal V; Mironneau J; Ojeda C; Gargouil YM
    Physiol Bohemoslov; 1970; 19(1):19-22. PubMed ID: 4394505
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the cardiac effects of several beta adrenergic blocking agents.
    Blinks JR
    Ann N Y Acad Sci; 1967 Feb; 139(3):673-85. PubMed ID: 4382727
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines.
    Ablad B; Brogård M; Carlsson E; Ek L
    Eur J Pharmacol; 1970; 13(1):59-64. PubMed ID: 4395676
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of propranolol and a new 'cardioselective' beta-blocker, H 93-26, on responses of isolated rat atria to isoprenaline and noradrenaline.
    Johansson B
    Eur J Pharmacol; 1973 Nov; 24(2):194-204. PubMed ID: 4148794
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.
    Levy JV
    Eur J Pharmacol; 1968 Feb; 2(4):250-7. PubMed ID: 4384450
    [No Abstract]   [Full Text] [Related]  

  • 16. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R; Delaunois G; Bauthier J
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract]   [Full Text] [Related]  

  • 17. Interrelationships between the contractile effects of metabolic substrates, beta-adrenergic blocking agents and endogenous catecholamine depletion on isolated rat atria.
    Gimeno MF; Clusella JA; Gimeno AL
    Experientia; 1970 Aug; 26(8):860-3. PubMed ID: 4393785
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of blocking the beta-adrenergic receptors on ventricular diastole and on the systole of the left atrium in normal subjects. (Evaluation with the polygraphic method)].
    Vitale P; Mazza F; Jacono A
    Minerva Cardioangiol; 1971 Aug; 19(8):418-23. PubMed ID: 4397763
    [No Abstract]   [Full Text] [Related]  

  • 20. A quantitative study of beta-adrenergic receptors in rabbit atria.
    Bristow M; Green RD
    Eur J Pharmacol; 1970 Sep; 12(1):120-3. PubMed ID: 4394343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.